Plenary Session 2104

Novel Clinical Trials in Movement Disorders

Saturday, February 14, 2026
10:15 - 12:00 | Houston Ballroom

In this session, the faculty will provide an in-depth overview of clinical trials on the management of motor and non-motor symptoms as well as motor fluctuations in Parkinson’s disease. They will also discuss disease-modifying therapies for atypical parkinsonisms, and clinical trials targeting essential tremor.

Chairs:

Alberto Espay, USA
William Ondo, USA

Presenters:

Novel Treatment Trials Targeting Parkinson’s Disease
Oscar Gershanik, Argentina

Novel Treatment Trials Targeting Atypical Parkinsonism
Anne-Marie Wills, USA

Novel Treatment Trials Targeting Essential Tremor
William Ondo, USA

CSPC Liaisons:

Alberto Espay, USA
Cecilia Peralta, Argentina

Learning Objectives

At the conclusion of this session, participants should be better able to:

1. Review the state-of-the-art of clinical trials for Phase 3 clinical trials in Parkinson´s disease targeting management of motor and non-motor symptoms as well as motor fluctuations.
2. Review the progress of clinical trials for disease-modifying therapies targeting cohorts in atypical parkinsonisms.
3. Describe advances in clinical trials for essential tremor.

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Researcher / Basic Science

Education Level

Experienced
Expert